<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00560807</url>
  </required_header>
  <id_info>
    <org_study_id>1 R21 AT004263</org_study_id>
    <nct_id>NCT00560807</nct_id>
  </id_info>
  <brief_title>Manual Therapy Dosage Factorial Study</brief_title>
  <official_title>Manual Therapy Dosage Factorial Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>McMaster University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Canadian Institutes of Health Research (CIHR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Western Ontario, Canada</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>McMaster University</source>
  <brief_summary>
    <textblock>
      This study will determine biological responses to different dosages of neck mobilization
      intervention in patients, providing opportunities to identify the optimal dosage, predictors
      of response, outcome measures as well as the longitudinal changes in biology.

      Subjects with acute whiplash associated disorders (WAD) II and III with a symptom duration of
      less than 30 days (acute) or 30 to 90 days (subacute) will be randomly assigned to receive
      different doses of mobilization. The dosage treatment groups will differ in the number of
      sessions (1, 2 or 3 times per week) and the duration of treatment (duration of treatment
      intervention will be 3, 6, or 12 weeks). A zero treatment/week option is included to insure
      that the impact of any mobilization is included and because previous studies suggest a single
      mobilization may have a treatment effect.

      All patient participants will receive a core standard treatment of education, advice to stay
      active, and neck/postural stretching and strengthening exercise. All patient participants
      will receive supervised exercise and advice for the full 12 weeks. All patients will be
      provided with an instructional CD and exercise brochure to reinforce the whole program.

      Follow-up assessments will consist of quantitative sensory testing (vibration threshold;
      current perception threshold), the Neck Walk Index (NWI), the Upper Cyclical Reach and Grasp
      Task, muscle biology analyses (cytokine analyses), central breathing control tests
      (capnography), range of motion, head flexion endurance, and self-report symptoms and
      disability (Visual Analogue Scale; Neck Disability Index; Disabilities of the Arm, Shoulder,
      Hand; pain threshold and tolerance algometry; and perceived self-efficacy; SF-36).

      Hypothesis: During recovery, patient are expected to transition from an acute painful state
      to one where they can resume normal activity and add intensive strengthening exercises.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    The study was stopped because the study never received funding
  </why_stopped>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quantitative Sensory Testing (QST)</measure>
    <time_frame>Within 24 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Current Perception Threshold (CPT)</measure>
    <time_frame>Within 24 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Neck Walk Index (NWI)</measure>
    <time_frame>Within 24 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cyclical Reach and Grasp Test (CRGT)</measure>
    <time_frame>Within 24 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Muscle Biology (cytokine analyses)</measure>
    <time_frame>Within 24 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Central Breathing Control Test</measure>
    <time_frame>Within 24 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Neck Disability Index</measure>
    <time_frame>Within 24 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Intensity - Visual Analogue Scale (VAS)</measure>
    <time_frame>Within 24 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Global Perceived Effect (GPE)</measure>
    <time_frame>Within 24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disabilities of the Arm, Shoulder, and Hand (DASH)</measure>
    <time_frame>Within 24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Threshold and Pain Tolerance Algometry</measure>
    <time_frame>Within 24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Head Flexion Endurance</measure>
    <time_frame>Within 24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Range of Motion</measure>
    <time_frame>Within 24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life (SF-36v2)</measure>
    <time_frame>within 24 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>12</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Whiplash Injuries</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Zero treatment/3 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Frequency of Mobilization:1/week Duration of Mobilization Treatment: 3 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Frequency of Mobilization: 1/week Duration of Mobilization Treatment: 6 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>D</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Frequency of Mobilization: 1/week Duration of Mobilization Treatment: 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>F</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Frequency of Mobilization: 2/week Duration of Mobilization Treatment: 3 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>G</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Frequency of Mobilization: 2/week Duration of Mobilization Treatment:6 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>H</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Frequency of Mobilization: 2/week Duration of Mobilization Treatment: 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>J</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Frequency of Mobilization: 3/week Duration of Mobilization Treatment: 3 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>K</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Frequency of Mobilization: 3/week Duration of Mobilization Treatment:6 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>L</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Frequency of Mobilization: 3/week Duration of Mobilization Treatment:12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>E</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Zero treatment/6 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>I</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Zero treatment/12 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Mobilization</intervention_name>
    <description>Mobilizations are passive movements performed in such a manner that the patient can volitionally prevent the movement. Types of mobilization include: a) passive oscillatory movements (2-3 Hz) of small or large amplitude, applied anywhere in a range of movement, typically for anything between 30 seconds and several minutes depending on the response and desired effects, and b) sustained stretching (glides) with or without tiny amplitude oscillations at the limit of the range.</description>
    <arm_group_label>B</arm_group_label>
    <arm_group_label>C</arm_group_label>
    <arm_group_label>D</arm_group_label>
    <arm_group_label>F</arm_group_label>
    <arm_group_label>G</arm_group_label>
    <arm_group_label>H</arm_group_label>
    <arm_group_label>J</arm_group_label>
    <arm_group_label>K</arm_group_label>
    <arm_group_label>L</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  acute whiplash associated disorders (WAD) II and III (113) with a symptom duration of
             less than 30 days or subacute (30 to 90 days)

          -  pain in the neck but may radiate to the shoulder region or upper extremities or have
             an associated headache

          -  pain intensity must be at or above 30 mm on a 100 mm visual analogue scale

          -  must be a new episode of pain with ,no other occurrences of neck pain requiring
             treatment in the previous 4 months.

        Exclusion Criteria:

          -  arthritis, neurological diseases, fractures, dislocation, rheumatoid arthritis, long
             tract signs and malignancy

          -  conditions that make the provision of neck exercise unsafe
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joy C MacDermid, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>McMaster University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>McMaster University</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8S 1C7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 19, 2007</study_first_submitted>
  <study_first_submitted_qc>November 19, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2007</study_first_posted>
  <last_update_submitted>September 22, 2015</last_update_submitted>
  <last_update_submitted_qc>September 22, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 23, 2015</last_update_posted>
  <responsible_party>
    <name_title>Joy MacDermid</name_title>
    <organization>McMaster University</organization>
  </responsible_party>
  <keyword>WAD II</keyword>
  <keyword>WAD III</keyword>
  <keyword>mobilization</keyword>
  <keyword>dosage</keyword>
  <keyword>acute whiplash associated disorders (WAD) II and III (113) with a symptom duration of less than 30 days</keyword>
  <keyword>neck pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Whiplash Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

